These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 15028478

  • 21. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
    Peng XY, Won JH, Rutherford T, Fujii T, Zelterman D, Pizzorno G, Sapi E, Leavitt J, Kacinski B, Crystal R, Schwartz P, Deisseroth A.
    Cancer Res; 2001 Jun 01; 61(11):4405-13. PubMed ID: 11389068
    [Abstract] [Full Text] [Related]

  • 22. Suicide gene therapy of sarcoma cell lines using recombinant adeno-associated virus 2 vectors.
    Veldwijk MR, Berlinghoff S, Laufs S, Hengge UR, Zeller WJ, Wenz F, Fruehauf S.
    Cancer Gene Ther; 2004 Aug 01; 11(8):577-84. PubMed ID: 15280909
    [Abstract] [Full Text] [Related]

  • 23. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
    Shirakawa T, Hamada K, Zhang Z, Okada H, Tagawa M, Kamidono S, Kawabata M, Gotoh A.
    Clin Cancer Res; 2004 Jul 01; 10(13):4342-8. PubMed ID: 15240520
    [Abstract] [Full Text] [Related]

  • 24. Expression and secretion of the beta subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro.
    Nishimura R, Koizumi T, Morisue K, Yamanaka N, Lalwani R, Yoshimura M, Nakagawa T, Shii K, Hasegawa K, Baba S.
    Cancer Res; 1995 Apr 01; 55(7):1479-84. PubMed ID: 7882356
    [Abstract] [Full Text] [Related]

  • 25. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
    Yan C, Wen-Chao L, Hong-Yan Q, Rui Z, Wei-Lin J, Hua H.
    Acta Oncol; 2007 Apr 01; 46(6):773-81. PubMed ID: 17653900
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
    Wang YP, Tang XJ, Zhou QH, Che GW, Chen XH, Zhu DX.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep 01; 39(5):701-5. PubMed ID: 19024294
    [Abstract] [Full Text] [Related]

  • 28. [The animal research of recombinant adenovirus controlled by human telomerase reverse transcriptase promoter in the treatment of human prostate cancer].
    Zhang Y, Qi JC, Lian WF, Cai WQ, Li W, Liu KL.
    Zhonghua Wai Ke Za Zhi; 2006 Sep 15; 44(18):1252-5. PubMed ID: 17147886
    [Abstract] [Full Text] [Related]

  • 29. Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.
    Melquist JJ, Kacka M, Li Y, Malaeb BS, Elmore J, Baseman AG, Hsieh JT, Koeneman KS.
    Urol Oncol; 2006 Sep 15; 24(4):362-71. PubMed ID: 16818192
    [Abstract] [Full Text] [Related]

  • 30. Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy.
    Deharvengt S, Wack S, Aprahamian M, Hajri A.
    J Gene Med; 2005 May 15; 7(5):672-80. PubMed ID: 15580629
    [Abstract] [Full Text] [Related]

  • 31. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
    Petrigliano FA, Virk MS, Liu N, Sugiyama O, Yu D, Lieberman JR.
    Prostate; 2009 Sep 15; 69(13):1422-34. PubMed ID: 19489029
    [Abstract] [Full Text] [Related]

  • 32. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
    Mathis JM, Williams BJ, Sibley DA, Carroll JL, Li J, Odaka Y, Barlow S, Nathan CO, Li BD, DeBenedetti A.
    J Gene Med; 2006 Sep 15; 8(9):1105-20. PubMed ID: 16802401
    [Abstract] [Full Text] [Related]

  • 33. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
    Wang WD, Chen ZT, Li DZ, Duan YZ, Wang ZX, Cao ZH.
    Ai Zheng; 2004 Jul 15; 23(7):788-93. PubMed ID: 15248913
    [Abstract] [Full Text] [Related]

  • 34. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y, Shen K, He CX.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep 15; 42(9):617-22. PubMed ID: 17983518
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Adenovirus-mediated double suicide gene therapy for experimental bladder carcinoma].
    Tan WL, Xie Y, Wu YD, Zhu WH, Zheng SB.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May 15; 26(5):594-7. PubMed ID: 16762858
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.
    Lee SE, Jin RJ, Lee SG, Yoon SJ, Park MS, Heo DS, Choi H.
    Anticancer Res; 2000 May 15; 20(1A):417-22. PubMed ID: 10769689
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Persistent adenovirus-mediated thymidine kinase gene expression in ovarian cancer cells increases cell killing efficacy over time.
    Kieback DG, Delvoux B, Romano A, Ollig S, Fischer DC.
    Anticancer Res; 2008 May 15; 28(5A):2569-75. PubMed ID: 19035280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.